The coupling agent used in the present invention can be selected from but not limited to N,N'-dicyclohexylcarbodiimide (DCC), N,N"-diisopropyl carbodiimide (DIC), l-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC.HC1), N,N"-carbonyl diimidazole (CDI), 1 -[bis(dimethylamino)methylene]- 1H- 1 ,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate (HATU), 2-(lH-benzotriazol-l-yl)-l,l,3,3-tetramethyluronium hexafluorophosphate (HBTU), IH-benzotriazolium l-[bis(dimethylamino)methylene]- 5-chloro-hexafluorophosphate( 1 )-3-oxide(HCTU), (benzotriazol- 1 -yloxy)tris (dimethylamino )phosphonium hexafluorophosphate (BOP), benzotriazol- 1-yl- oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP), l-hydroxy-7-azatriazole (HOAt), 1-hydroxy benzotriazole (HOBt),l-hydroxy-lH-l,2,3-triazole-4-carboxylate (HOCt),O-(benzotriazol-l-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TBTU), N- hydroxysuccinamide (HOSu), N-hydroxysulfosuccinimide (Sulfo-NHS), ethyl cyanohydroxyiminoacetate (Oxyma), 7 -Azabenzotriazol- 1 -yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyAOP), N,N,N',N'-Tetramethyl-O-(N-succinimidyl)uronium tetrafluoroborate (TSTU) or mixtures thereof

Contrave (naltrexone/bupropion) and Wegovy (semaglutide) are brand-name medications prescribed to help certain adults lose weight and keep it off
The presence of peripheral artery disease (PAD), in particular, is associated with worsened survival rate compared with disease limited to other vascular beds [4]
Dosage and consistency: Higher doses and regular sessions can accelerate the process